Big news: idegy is now officially licensed with @SInow! Bringing that iconic sports legacy to life through merch, game-day promos, retail, hospitality & more.
Read more: https://t.co/AvaS3rxlPb
💸 Why Trulieve & Curaleaf getting added to indices matters
— Anthony Varrell @V_arrell
Two press releases landed this week that read like housekeeping and are anything but. On Monday, Trulieve @Trulieve (NYSE: $TRLV) announced it had been added to the S&P Total Market Index and the S&P Completion Index, along with their health care sub-indices. On Wednesday, Curaleaf @Curaleaf_Inc (TSX: $CURA) said it had joined the FTSE Canada All Cap Index, its second major Canadian benchmark after entering the S&P/TSX Composite a year ago. Neither headline will move a stock 20% in a day. Both change who is allowed to own it, and in a sector that has spent a decade locked out of institutional portfolios, that is the whole game.
Why it matters
Roughly a third of U.S. equity assets sit in passive vehicles that don't pick stocks — they buy whatever the index says to buy, in the weight the index says to hold it. A company outside every index is, for that pool of capital, invisible. It can be profitable, growing and cheap, and Vanguard's Extended Market fund will still never own a share because the rulebook doesn't allow it.
Index inclusion flips that switch. Once a stock is in the S&P Completion Index, funds tracking it are obligated to buy, at reconstitution, in proportion to float-adjusted market cap. That creates a permanent bid that doesn't care about rescheduling rumors, ALJ timelines or 280E. It buys on inflows and sells on outflows, mechanically, every day. For a stock that has traded on retail sentiment and OTC liquidity for its entire life, replacing a slice of that shareholder base with index money reduces volatility, tightens spreads and lowers the cost of capital.
It also unlocks the active money that sits downstream. Most institutional mandates are benchmarked; a portfolio manager can't take a position in a name that isn't in her benchmark universe without a compliance conversation. Once Trulieve is in the TMI, it's in the opportunity set for every U.S. all-cap and small-cap manager measured against S&P. Kim Rivers' line about "attracting new institutional investors" is not aspirational — it's a description of how mandates work.
How it happens
Index inclusion isn't something a company applies for. It's the mechanical output of meeting eligibility rules that, for U.S. cannabis, were impossible to satisfy until this year.
The S&P Total Market Index is designed to capture essentially every investable U.S. stock. To get in, a company needs to be U.S.-domiciled, listed on a major U.S. exchange (NYSE, Nasdaq or Cboe), meet a minimum float and liquidity threshold, and pass S&P's screens on financial viability. The Completion Index is the TMI minus the S&P 500 — the 3,000-plus mid, small and micro caps that fill out the market — and it's the direct benchmark for Vanguard's Extended Market ETF and a range of institutional completion strategies.
Trulieve checked every box in sequence. It restructured to medical-only under Schedule III, which eliminated the federal-illegality problem that kept the NYSE's door shut. It redomiciled to the United States, which cleared the domicile requirement. It listed on the NYSE in June. Three months later S&P's quarterly rebalance picked it up, because the rules said it should. The entire path took roughly a year and required the DEA's April rule to make the medical-only entity legally distinct from the adult-use business. That wasn't an accident of timing. It was the plan.
Curaleaf's route ran through Toronto. The TSX accepted its listing in 2023, the S&P/TSX Composite added it in September 2025, and the FTSE Canada All Cap — the benchmark behind Vanguard's Canadian all-cap ETF and a slate of pension mandates — followed this month. The mechanics are the same: exchange listing first, then eligibility, then a rules-based provider adds you at the next review. Boris Jordan's framing is the right one: every index brings the shares in front of a new set of passive and active funds, and the effect compounds.
What comes next for Trulieve
S&P was the first domino, not the last. The Russell reconstitution is the bigger prize — the Russell 2000 and 3000 are the dominant small-cap benchmarks in the U.S., with far more passive money tracking them than the S&P Completion Index. FTSE Russell has moved to a semiannual schedule, which means Trulieve's next window comes later this year rather than next June. CRSP, the index family behind Vanguard's Total Stock Market ETF, rebalances quarterly. MSCI's U.S. small-cap indices review on their own cycle. Each one adds another layer of structural demand, and each one applies the same test Trulieve just passed.
Who follows, and how
The template is now public, and every operator with U.S. exchange ambitions is working through the same checklist.
Green Thumb has said for years it would list on a U.S. exchange the moment the rules permit. It's a British Columbia company, so domestication would be required for S&P eligibility, and its adult-use exposure means it likely needs the ALJ's decision to extend Schedule III before the NYSE or Nasdaq will accept it. It has the balance sheet, the buyback discipline and the governance already in place; what it's waiting on is the DEA.
Verano did a 1-for-5 reverse split in June specifically to meet minimum share price requirements for a U.S. listing application, and amended its buyback to match the new count. That's a company that's already filled out the paperwork.
Cresco disclosed one-time costs for "preparations for a potential U.S. exchange listing" in its last quarter. TerrAscend has been a TSX issuer since 2023 and has the compliance infrastructure. Glass House is already on the NYSE alongside Trulieve, though as a Canadian-domiciled issuer its path into U.S. indices is more complicated.
The fork in the road for all of them is the one Trulieve chose: ring-fence medical operations and list now, or wait for full rescheduling and list whole. If the ALJ recommends Schedule III for all cannabis and the DEA administrator adopts it, the second path opens for everyone at once, and the exchanges will process a wave of applications in early 2027. Every one of those listings triggers the same sequence Trulieve just completed — S&P, then Russell, then CRSP — and each one brings the sector's float-adjusted market cap further inside the passive universe.
The bottom line
Cannabis has spent years arguing it deserves institutional capital. Index inclusion is the mechanism by which that capital actually arrives. Trulieve's S&P addition is the first proof that a plant-touching U.S. operator can clear every gate, and Curaleaf's FTSE inclusion shows the same logic working on the TSX. The rest of the sector now has a map. What it doesn't have yet is the rescheduling decision that lets everyone follow it.
🌿 Cannabis ETFs: 🌎 $YOLO 🇺🇸 $MSOS
@Curaleaf_Inc is now part of the @FTSERussell Canada All Cap Index, our second major Canadian benchmark in a year! Each inclusion broadens our visibility and shareholder base, bringing more attention to $CURA and the opportunity ahead for U.S. cannabis. $CURLF https://t.co/RHBaoRukxb
If this is the 2026 version of the Steelers - let the young QBs get experience. No reason to wait. Patriots aren’t good - imagine what this will look like against good teams. Turn the page.
Federal Court Rejects Marijuana Opponents' Request To Block Trump's Rescheduling Move: "Petitioners have not satisfied the stringent requirements for a stay pending court review."
https://t.co/2xHS7OnoY3
Jordy Nelson made more than $56 million playing in the NFL.
He spends his days on a farm in Kansas, driving a combine.
The farm sits between Riley and Leonardville, two towns with a combined population of about 1,500, roughly 50 miles west of Topeka. Four thousand acres. A thousand head of cattle.
His great-great-grandfather started it after immigrating from Sweden. It's been in the family four generations.
Nelson was driving tractor loads of wheat into town at 12 years old, before he had a license.
He went to Kansas State, caught a school record 122 passes as a senior, and Green Bay took him in the second round in 2008.
Then he became one of the best receivers in football. A 1,519 yard season in 2014, a Packers record. Fourteen touchdowns to lead the NFL in 2016. Nine catches for 140 yards and a score in Super Bowl XLV. Aaron Rodgers threw to him more than anybody.
He finished with 613 catches, 8,587 yards and 72 touchdowns over 10 seasons.
Here's what he did every offseason while all that was happening.
He went home and worked.
Five or six weeks a year, driving a combine through the wheat harvest, sometimes 12 hours a day. Rounding up cattle. Doing the same jobs he'd done as a kid.
"Working cattle is my favorite farm duty," he told ESPN back in 2015, at the peak of his career. "It's interactive, and you're on your feet all day."
Then he said the thing that tells you everything.
"I probably identify more as a farmer than a football player. Around here, I'm just the farm kid that they have always known."
His brother Mike, 18 months older, runs the operation.
In 2016, Nelson told Wisconsin Agriculturalist what he planned to do when football ended.
"I want to be my brother's hired man."
Not owner. Not investor. Hired man.
A year later he explained it a little more to Successful Farming.
"We plan on moving back home to Kansas and working with my brother on the farm. I told him he can lay me off whenever he wants and I'll go on vacation."
He retired in 2019 and did exactly that. He lives in Kansas now with his wife Emily and their sons, working the same ground his family has worked for four generations.
Bill Snyder, his coach at Kansas State, described him in a way that reads differently once you know where he ended up.
"He is the epitome of consistency. He's not one way one day and another way the next day. He's the same Jordy Nelson, day in and day out. There's no pretense to him whatsoever."
Nelson put it his own way.
"It set the foundation of who I am. The hard work, the day-in, day-out grind. Understanding that you have to go to work every day."
For more stories like this, follow us on any platform @thesportsontap
Boston is a dynamic market with a thriving cannabis community. Our new location near Downtown Crossing is an exciting opportunity for @Curaleaf_Inc to deepen our connection to the city and better serve our customers and patients. $CURA $CURLF https://t.co/Sdrx2n764j
A moment they'll never forget 👏
Join us on Saturday, November 14 as we honor this year’s Penguins Hall of Fame inductees with a pregame ceremony: https://t.co/PCsKRL7681
A well-earned place among the greats.
The Penguins have named Marc-Andre Fleury, Larry Murphy, Jim Rutherford, and Jack McGregor to the Penguins Hall of Fame Class of 2026.